Feasibility of detecting Amyloid burden in preclinical Alzheimer's disease with quantitative magnetization transfer MRI
Andrew Mao, Sebastian Flassbeck, Elisa Marchetto, Henry Rusinek, Jakob Assländer · 2025
Read Feasibility of detecting Amyloid burden in preclinical Alzheimer's disease with quantitative magnetization transfer MRI by Andrew Mao, Sebastian Flassbeck, Elisa Marchetto, Henry Rusinek, Jakob Assländer (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712749.txt.
Description
Andrew Mao, Sebastian Flassbeck, Elisa Marchetto, Henry Rusinek, and Jakob Assländer test a brain scan method, published in 2025, that might track amyloid without tracers. The method is called quantitative magnetization transfer MRI. It senses large molecules in tissue, and amyloid is one of them. Earlier work suggested it could separate patients from healthy people. The team asked whether it works before symptoms start.
Fourteen people with no thinking problems took the special scan, which took twelve minutes. Standard scans mapped each brain, and past tracer scans gave amyloid levels. Two measures from the new scan fell as amyloid rose, most clearly in the temporal lobe. One of those links is new, since most methods fix that value. The size of the large-molecule pool did not change. The authors call the method promising but say a larger group must confirm it.
Catalog record
| CREATOR | Andrew Mao, Sebastian Flassbeck, Elisa Marchetto, Henry Rusinek, Jakob Assländer |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |